SCHEMBL23928897

SCHEMBL23928897

O=C1CC2(CN(C(=O)NCc3ccc4[nH]ccc4c3)C2)Oc2ccc(Cl)cc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 14/20 0.64
▸ KCNH2 Q12809 2/20 0.43
▸ ACACB O00763 1/20 0.42
▸ EPHX1 P07099 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ METAP2 P50579 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ HDAC3 O15379 2/20 0.38
▸ HDAC4 P56524 2/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ HDAC7 Q8WUI4 2/20 0.38
▸ HDAC2 Q92769 2/20 0.38
▸ HDAC10 Q969S8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31020809 1.00 CHRNA7 (0.64) CHRNA7KCNH2ACACBEPHX1CYP2D6
SCHEMBL23957090 0.92 CHRNA7 (0.55) CHRNA7KCNH2ACACBEPHX1CYP2D6
SCHEMBL23957173 0.88 CHRNA7 (0.82) CHRNA7ACACBKDM4EALDH1A1GLA
SCHEMBL31020806 0.86 CHRNA7 (0.82) CHRNA7KDM4EALDH1A1GAAHPGD
SCHEMBL23928866 0.86 CHRNA7 (0.82) CHRNA7KDM4EALDH1A1GAAHPGD
SCHEMBL23957115 0.84 CHRNA7 (0.76) CHRNA7KCNH2EPHX1CYP2D6EPHX2
SCHEMBL21617951 0.82 CHRNA7 (0.80) CHRNA7
SCHEMBL31020810 0.82 CHRNA7 (0.80) CHRNA7
SCHEMBL23928868 0.81 CHRNA7 (0.82) CHRNA7ACACBHPGDHDAC8HDAC6
SCHEMBL23957136 0.80 CHRNA7 (0.44) CHRNA7KCNH2EPHX1CYP2D6EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 — — EP claimed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 — — US claimed
CN-112823157-A Spirochroman derivatives 吉瑞工厂 2021-05-18 — — CN claimed
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 — — EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 — — US disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 — — US disclosed
CN-112823157-A Spirochroman derivatives 吉瑞工厂 2021-05-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 CHRNA7 1/4885KCNH2 385/4885ACACB 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback